Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanxia Guo

Showing results (81-90 of 111) with videos related to

Pageof 12
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 1, 2022
Photodynamic therapy-improved oncolytic bacterial immunotherapy with FAP-encoding S. typhimuriumYanxia Guo, Mingxia Song, Xiaoqing Liu, et al.
Plos One|September 2, 2017
Triple DMARD treatment in early rheumatoid arthritis modulates synovial T cell activation and plasmablast/plasma cell differentiation pathwaysAlice M Walsh, Mihir D Wechalekar, Yanxia Guo, et al.
Archives of Dermatological Research|July 27, 2018
LY2109761 reduces TGF-β1-induced collagen production and contraction in hypertrophic scar fibroblastsGuo Wei, Qingqing Xu, Lin Liu, et al.
Oncology Letters|February 14, 2018
Enhancement of cisplatin cytotoxicity by Retigeric acid B involves blocking DNA repair and activating DR5 in prostate cancer cellsYongqing Liu, Chunwen Yue, Juan Li, et al.
Oncology Letters|August 13, 2020
Polyphyllin II inhibits human bladder cancer migration and invasion by regulating EMT-associated factors and MMPsWeipin Niu, Li Xu, Jingwei Li, et al.
BMC Microbiology|August 2, 2024
Effects of berberine hydrochloride on antioxidant response and gut microflora in the Charybdis japonica infected with Aeromonas hydrophilaMingming Han, Yanxia Guo, ShengKai Tang, et al.
Theranostics|November 1, 2023
Engineered oncolytic bacteria HCS1 exerts high immune stimulation and safety profiles for cancer therapyYujie Sun, Yanxia Guo, Xiaoqing Liu, et al.
Oncology Reports|October 4, 2019
Downregulation of MUTYH contributes to cisplatin‑resistance of esophageal squamous cell carcinoma cells by promoting Twist‑mediated EMTYanxia Guo, Yuxiu Jia, Shikang Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 17, 2021
Targeting of pancreatic cancer cells and stromal cells using engineered oncolytic Salmonella typhimuriumWenzhi Tan, Mai Thi-Quynh Duong, Chaohui Zuo, et al.
Journal of Medicinal Chemistry|April 10, 2015
ent-Kaurane Diterpenoids from Chinese Liverworts and Their Antitumor Activities through Michael Addition As Detected in Situ by a Fluorescence ProbeZhaomin Lin, Yanxia Guo, Yanhui Gao, et al.
Pageof 12

Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 1, 2022
Photodynamic therapy-improved oncolytic bacterial immunotherapy with FAP-encoding S. typhimuriumYanxia Guo, Mingxia Song, Xiaoqing Liu, et al.
Plos One|September 2, 2017
Triple DMARD treatment in early rheumatoid arthritis modulates synovial T cell activation and plasmablast/plasma cell differentiation pathwaysAlice M Walsh, Mihir D Wechalekar, Yanxia Guo, et al.
Archives of Dermatological Research|July 27, 2018
LY2109761 reduces TGF-β1-induced collagen production and contraction in hypertrophic scar fibroblastsGuo Wei, Qingqing Xu, Lin Liu, et al.
Oncology Letters|February 14, 2018
Enhancement of cisplatin cytotoxicity by Retigeric acid B involves blocking DNA repair and activating DR5 in prostate cancer cellsYongqing Liu, Chunwen Yue, Juan Li, et al.
Oncology Letters|August 13, 2020
Polyphyllin II inhibits human bladder cancer migration and invasion by regulating EMT-associated factors and MMPsWeipin Niu, Li Xu, Jingwei Li, et al.
BMC Microbiology|August 2, 2024
Effects of berberine hydrochloride on antioxidant response and gut microflora in the Charybdis japonica infected with Aeromonas hydrophilaMingming Han, Yanxia Guo, ShengKai Tang, et al.
Theranostics|November 1, 2023
Engineered oncolytic bacteria HCS1 exerts high immune stimulation and safety profiles for cancer therapyYujie Sun, Yanxia Guo, Xiaoqing Liu, et al.
Oncology Reports|October 4, 2019
Downregulation of MUTYH contributes to cisplatin‑resistance of esophageal squamous cell carcinoma cells by promoting Twist‑mediated EMTYanxia Guo, Yuxiu Jia, Shikang Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 17, 2021
Targeting of pancreatic cancer cells and stromal cells using engineered oncolytic Salmonella typhimuriumWenzhi Tan, Mai Thi-Quynh Duong, Chaohui Zuo, et al.
Journal of Medicinal Chemistry|April 10, 2015
ent-Kaurane Diterpenoids from Chinese Liverworts and Their Antitumor Activities through Michael Addition As Detected in Situ by a Fluorescence ProbeZhaomin Lin, Yanxia Guo, Yanhui Gao, et al.
Pageof 12